Furthermore, our results did not exhibit effect of either GSTO1 (rs4925) or GSTO2 (rs156697 and rs2297235) polymorphisms on overall survival among female ccRCC patients (Figure 1c). This evidence concerns the gene GSTO1 and nonpapillary renal cell carcinoma.